Consolidated Net Income/Loss (Annual)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

Phibro Animal Health Corporation (PAHC) had Consolidated Net Income/Loss of $32.61M for the most recently reported fiscal year, ending 2023-06-30.

Quarterly Annual

Figures for fiscal year ending 2023-06-30

Income Statement Financials
Revenue	$977.89M
Net Income	$32.61M
Cost of Goods Sold	$679.65M
Gross Profit	$298.24M
Operating Expenses	$906.04M
Operating Income	$71.85M
Non-Operating Income/Expense	$-17.78M
Pre-Tax Income	$54.07M
Normalized Pre-Tax Income	$54.07M
Income after Taxes	$32.61M
Income from Continuous Operations	$32.61M
Consolidated Net Income/Loss	$32.61M
Normalized Income after Taxes	$32.61M
EBIT	$71.85M
EBITDA	$106.59M
Weighted-Average Shares Outstanding (Basic)	40.50M
Weighted-Average Shares Outstanding (Diluted)	40.50M
Earnings per Share (EPS) (Basic)	$0.81
Earnings per Share (EPS) (Diluted)	$0.81
Balance Sheet Financials
Current Assets	$585.72M
Property, Plant, and Equipment	$195.57M
Long-Term Assets	$385.67M
Total Assets	$971.40M
Current Liabilities	$176.00M
Long-Term Debt	$452.54M
Long-Term Liabilities	$512.89M
Total Liabilities	$688.89M
Common Equity	$282.51M
Tangible Shareholders Equity	$174.25M
Shareholders Equity	$282.51M
Common Shares Outstanding	40.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$13.31M
Cash Flow from Investing Activities	$-74.02M
Cash Flow from Financial Activities	$26.99M
Beginning Cash	$74.25M
End Cash	$41.28M
Increase/Decrease in Cash	$-32.97M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-19.44M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.33
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.62
Debt to Equity Ratio	1.68
Gross Margin	30.50%
Operating Margin	7.35%
EBIT Margin	7.35%
EBITDA Margin	10.90%
Pre-Tax Profit Margin	5.53%
Profit Margin	3.33%
Free Cash Flow	$-38.48M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.01
Inventory Turnover	2.45
Receiveable Turnover	5.98
Days Sales in Receivables	61.02
Return on Equity	11.54%
Return on Tangible Equity	18.71%
Return on Assets	3.36%
Return on Investments	4.44%
Book Value Per Share	$6.97
Free Cash Flow per Share	$-0.95
Operating Cash Flow per Share	$0.33

Data from Zacks Investment Research, Inc.